Regulatory filing of first-in-human (FIH) trial of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) anticipated in the second half of 2024 —Preclinical data presented at the American ...
Some results have been hidden because they may be inaccessible to you